Heart scan to assess heart risk before kidney transplant
Tests a heart scan to find people awaiting kidney transplant at highest heart risk.
Plain-language title generated from the registry record
Registry title: Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation
Key facts
- Where
- Edinburgh, Glasgow, London, Plymouth, and Sheffield, United KingdomSee the 5 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with kidney failure who are on the waiting list for a kidney transplant. A heart scan (CTCA) will be used to check their heart risk before transplant.
- Age
- 16 years and over
- Sex
- All sexes can join.
- Disease stage
- Kidney failure, on the waitlist for a kidney transplant.
Main reasons for not taking part
- Cannot have a CT scan, including allergy to the scan contrast dye
- Being considered for a kidney-pancreas, kidney-liver or kidney-islet transplant at the same time
- Unable to give informed consent
Read by machine on 9 November 2026.
Where in United Kingdom
- Royal Infirmary of EdinburghEdinburgh, United KingdomContact: Gavin B Chapman, MBChBTaking people
- Queen Elizabeth HospitalGlasgow, United KingdomContact: Rajan Patel, MBChBTaking people
- Imperial College Healthcare NHS TrustLondon, United KingdomContact: Christopher BakerTaking people
- University Hospitals Plymouth NHS TrustPlymouth, United KingdomContact: Kris HoulbergTaking people
- Sheffield teaching Hospitals NHS TrustSheffield, United KingdomContact: William McKaneTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Edinburgh
- Trial code
- NCT06234410
- Record updated
- 5 November 2026
- Original description
Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation.Read full original descriptionShow less
Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation
Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation.
Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes.
This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function.
The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.
Inclusion: Has kidney failure and is on the waitlist for a kidney transplant; Age 16 years and over; Able to give informed consent.
Exclusion: Patients being considered for a simultaneous kidney-pancreas, kidney-liver and/or kidney-islet transplantation; Contraindication to CT scanning, including contrast allergy; Inability to give informed consent.